These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8597862)
1. Giant cell tumor in the skull of a 9-year-old child: immunohistochemistry to confirm a diagnosis rare for age and site. Curilovic A; Eich GF; Stallmach T Pediatr Pathol Lab Med; 1995; 15(5):769-79. PubMed ID: 8597862 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy. Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500 [TBL] [Abstract][Full Text] [Related]
3. Giant cell tumor of the skull in pediatric patients. Report of two cases. Elder JB; Berry C; Gonzalez-Gomez I; Kreger MD; McComb JG J Neurosurg; 2007 Jul; 107(1 Suppl):69-74. PubMed ID: 17644925 [TBL] [Abstract][Full Text] [Related]
4. Selected Giant Cell Rich Lesions of the Temporal Bone. Martinez AP; Torres-Mora J Head Neck Pathol; 2018 Sep; 12(3):367-377. PubMed ID: 30069841 [TBL] [Abstract][Full Text] [Related]
5. [Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques]. Macagno N; Caselles K; Aubert S; Audard V; Gomez-Brouchet A; Galant C; Guinebretière JM; Karanian M; Larousserie F; Marie B; de Pinieux G; Bouvier C Ann Pathol; 2018 Apr; 38(2):92-102. PubMed ID: 29580573 [TBL] [Abstract][Full Text] [Related]
6. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions. Shooshtarizadeh T; Rahimi M; Movahedinia S Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669 [TBL] [Abstract][Full Text] [Related]
7. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone. Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220 [TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic differential diagnosis of giant cell-rich osteosarcoma and giant cell tumor of bone]. Huang J; Jiang Z; Zhang H Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):379-82. PubMed ID: 25208987 [TBL] [Abstract][Full Text] [Related]
9. Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience. Hammas N; Laila C; Youssef AL; Hind el F; Harmouch T; Siham T; Afaf A Diagn Pathol; 2012 Sep; 7():130. PubMed ID: 23016917 [TBL] [Abstract][Full Text] [Related]
10. Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients. Al-Ibraheemi A; Inwards CY; Zreik RT; Wenger DE; Jenkins SM; Carter JM; Boland JM; Rose PS; Jin L; Oliveira AM; Fritchie KJ Am J Surg Pathol; 2016 Dec; 40(12):1702-1712. PubMed ID: 27526293 [TBL] [Abstract][Full Text] [Related]
11. [Giant-cell tumor of bone in 2022]. Larousserie F; Audard V; Burns R; de Pinieux G Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609 [TBL] [Abstract][Full Text] [Related]
12. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern. Stagner AM; Sajed DP; Nielsen GP; Ebb DH; Faquin WC; Chebib I; Rivera MN; Ting DT; Resnick CM; Peacock ZS; Kaban LB; Deshpande V Am J Surg Pathol; 2019 Jun; 43(6):819-826. PubMed ID: 30998511 [TBL] [Abstract][Full Text] [Related]
13. Giant cell tumor of the skull: a case report and review of the literature. Harris AE; Beckner ME; Barnes L; Kassam A; Horowitz M Surg Neurol; 2004 Mar; 61(3):274-7. PubMed ID: 14985001 [TBL] [Abstract][Full Text] [Related]
14. Denosumab Therapy Obscures Histological Features of Giant Cell Tumor of Bone. Gilani A; Kleinschmidt-DeMasters BK J Neuropathol Exp Neurol; 2019 Dec; 78(12):1171-1173. PubMed ID: 31665371 [TBL] [Abstract][Full Text] [Related]
15. Chondroblastoma-like chondroma of soft tissue: report of the first case in the base of skull. Raparia K; Lin JW; Donovan D; Vrabec JT; Zhai QJ; Ayala AA; Ro JY Ann Diagn Pathol; 2013 Jun; 17(3):298-301. PubMed ID: 22743240 [TBL] [Abstract][Full Text] [Related]
16. [Differential diagnosis of giant cell-rich lesions of bone]. Lang S Pathologe; 2008 Nov; 29 Suppl 2():245-9. PubMed ID: 18836722 [TBL] [Abstract][Full Text] [Related]
17. Histopathology of giant cell tumors of the bone: With special emphasis on fibrohistiocytic and aneurysmal bone cyst like components. Çomunoğlu N; Kepil N; Dervişoğlu S Acta Orthop Traumatol Turc; 2019 Jan; 53(1):35-39. PubMed ID: 30392920 [TBL] [Abstract][Full Text] [Related]
18. Anti-histone H3.3K36M Antibody is a Highly Sensitive and Specific Immunohistochemistry Marker for the Diagnosis of Chondroblastoma. A Validation Based on Study 136 Cases Comprising Chondroblastoma and its Mimics from Single a Centre in India. Hui M; Uppin SG; Narayanan R; Kancherla NR; Kamble A; B RR; Patnala C Int J Surg Pathol; 2023 Jun; 31(4):375-386. PubMed ID: 35786027 [No Abstract] [Full Text] [Related]
19. Utility of P63 in Differentiating Giant Cell Tumor from Other Giant Cell-Containing Lesions. Hui M; Uppin SG; Kumar KK; Radhika S; Chandrasekhar P; Rao KN Turk Patoloji Derg; 2022; 38(1):9-15. PubMed ID: 34514571 [TBL] [Abstract][Full Text] [Related]
20. Giant cell bone lesions in the craniofacial region: a diagnostic and therapeutic challenge. Borges BB; Fornazieri MA; Bezerra AP; Martins LA; Pinna Fde R; Voegels RL Int Forum Allergy Rhinol; 2012 Nov; 2(6):501-6. PubMed ID: 22566483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]